FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044985462> ?p ?o ?g. }

• W2044985462 endingPage "764" @default.
• W2044985462 startingPage "759" @default.
• W2044985462 abstract "Background:131I therapy is effective in reducing the volume of large nodular goiters (thyroid volume [TV]), mainly after stimulation with recombinant human thyrotropin (rhTSH). The amount of 131I to be administered inversely depends on thyroid radioactive iodine uptake (RAIU). In patients with low RAIU, we evaluated the efficacy of 131I treatment at lower doses with respect to those calculated on the basal RAIU, after rhTSH stimulation. Methods: Eighteen consecutive patients (17 women and 1 man, 49–83 years) with large nodular goiter were included in the study. At enrolment, 24th h RAIU, TSH, free thyroxine, free triiodothyronine, thyroglobulin antibodies, thyroid peroxidase antibodies, TSH receptors antibodies, urinary iodine, and TV were measured. RAIU was <40% in 11 patients (lower uptake group [LUG]) and >40% in 7 (higher uptake group [HUG]). RAIU difference in the two groups was significant (p < 0.0001). LUG patients were treated with rhTSH (0.03 mg i.m.) and RAIU was measured again after 24 hours. The administered amount of 131I was aimed to give the thyroid a dose of 100 Gy, by the formula: 131I activity = 370 MBq × TV (mL)/RAIU(%), taking into account RAIU value after rhTSH for LUG patients. Patients were re-evaluated 3 and 12 months after therapy. Results: At enrolment, LUG and HUG patients did not differ for TV, free thyroxine, free triiodothyronine, TSH, and urinary iodine. LUG patients were older than HUG patients (p = 0.027). In LUG, the uptake increased after rhTSH (42.8% [36%–47.5%] vs. 30% [23.4%–31.6%], p = 0.0044). The 131I activity was 1073 MBq (740–1103 MBq) in LUG and 851 MBq (677–918 MBq) in HUG (p = 0.22, NS), vs. 1300 MBq (1077–2150 MBq) in LUG, based on RAIU before rhTSH. At 3 and 12 months after radioiodine, TV was reduced to 74% [59%–84%] and 53% [42%–72%] in LUG and 75% [70%–77%] and 65% [54%–74%] in HUG, respectively. The reduction was significant with respect to the basal, both at 3 and 12 months, but not different between the two groups. Conclusions: One single dose of 0.03 mg of rhTSH increased the thyroid RAIU by 40% in patients with nodular goiter and low basal uptake. This allowed a mean reduction of 36% (26%–42%) in the administered 131I activity without loss of effectiveness. In patients with low RAIU, rhTSH pre-treatment may optimize 131I therapy." @default.
• W2044985462 created "2016-06-24" @default.
• W2044985462 creator A5003531480 @default.
• W2044985462 creator A5014279456 @default.
• W2044985462 creator A5026164072 @default.
• W2044985462 creator A5039824523 @default.
• W2044985462 creator A5046100468 @default.
• W2044985462 creator A5056320473 @default.
• W2044985462 creator A5069736956 @default.
• W2044985462 creator A5074571212 @default.
• W2044985462 creator A5089066322 @default.
• W2044985462 creator A5091827788 @default.
• W2044985462 date "2011-07-01" @default.
• W2044985462 modified "2023-09-27" @default.
• W2044985462 title "Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake" @default.
• W2044985462 cites W1970219548 @default.
• W2044985462 cites W1997556550 @default.
• W2044985462 cites W2000784270 @default.
• W2044985462 cites W2015287699 @default.
• W2044985462 cites W2020676616 @default.
• W2044985462 cites W2030303564 @default.
• W2044985462 cites W2033194982 @default.
• W2044985462 cites W2033676871 @default.
• W2044985462 cites W2037925360 @default.
• W2044985462 cites W2053669525 @default.
• W2044985462 cites W2069696291 @default.
• W2044985462 cites W2093832760 @default.
• W2044985462 cites W2100992577 @default.
• W2044985462 cites W2102109637 @default.
• W2044985462 cites W2107492396 @default.
• W2044985462 cites W2124584175 @default.
• W2044985462 cites W2151609680 @default.
• W2044985462 doi "https://doi.org/10.1089/thy.2010.0088" @default.
• W2044985462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21568727" @default.
• W2044985462 hasPublicationYear "2011" @default.
• W2044985462 type Work @default.
• W2044985462 sameAs 2044985462 @default.
• W2044985462 citedByCount "21" @default.
• W2044985462 countsByYear W20449854622012 @default.
• W2044985462 countsByYear W20449854622013 @default.
• W2044985462 countsByYear W20449854622014 @default.
• W2044985462 countsByYear W20449854622015 @default.
• W2044985462 countsByYear W20449854622016 @default.
• W2044985462 countsByYear W20449854622017 @default.
• W2044985462 countsByYear W20449854622018 @default.
• W2044985462 countsByYear W20449854622019 @default.
• W2044985462 countsByYear W20449854622020 @default.
• W2044985462 countsByYear W20449854622021 @default.
• W2044985462 crossrefType "journal-article" @default.
• W2044985462 hasAuthorship W2044985462A5003531480 @default.
• W2044985462 hasAuthorship W2044985462A5014279456 @default.
• W2044985462 hasAuthorship W2044985462A5026164072 @default.
• W2044985462 hasAuthorship W2044985462A5039824523 @default.
• W2044985462 hasAuthorship W2044985462A5046100468 @default.
• W2044985462 hasAuthorship W2044985462A5056320473 @default.
• W2044985462 hasAuthorship W2044985462A5069736956 @default.
• W2044985462 hasAuthorship W2044985462A5074571212 @default.
• W2044985462 hasAuthorship W2044985462A5089066322 @default.
• W2044985462 hasAuthorship W2044985462A5091827788 @default.
• W2044985462 hasConcept C126322002 @default.
• W2044985462 hasConcept C126894567 @default.
• W2044985462 hasConcept C134018914 @default.
• W2044985462 hasConcept C178790620 @default.
• W2044985462 hasConcept C180650514 @default.
• W2044985462 hasConcept C185592680 @default.
• W2044985462 hasConcept C2776254400 @default.
• W2044985462 hasConcept C2778835679 @default.
• W2044985462 hasConcept C2908975369 @default.
• W2044985462 hasConcept C2993294228 @default.
• W2044985462 hasConcept C3018694869 @default.
• W2044985462 hasConcept C526584372 @default.
• W2044985462 hasConcept C539932907 @default.
• W2044985462 hasConcept C71924100 @default.
• W2044985462 hasConceptScore W2044985462C126322002 @default.
• W2044985462 hasConceptScore W2044985462C126894567 @default.
• W2044985462 hasConceptScore W2044985462C134018914 @default.
• W2044985462 hasConceptScore W2044985462C178790620 @default.
• W2044985462 hasConceptScore W2044985462C180650514 @default.
• W2044985462 hasConceptScore W2044985462C185592680 @default.
• W2044985462 hasConceptScore W2044985462C2776254400 @default.
• W2044985462 hasConceptScore W2044985462C2778835679 @default.
• W2044985462 hasConceptScore W2044985462C2908975369 @default.
• W2044985462 hasConceptScore W2044985462C2993294228 @default.
• W2044985462 hasConceptScore W2044985462C3018694869 @default.
• W2044985462 hasConceptScore W2044985462C526584372 @default.
• W2044985462 hasConceptScore W2044985462C539932907 @default.
• W2044985462 hasConceptScore W2044985462C71924100 @default.
• W2044985462 hasIssue "7" @default.
• W2044985462 hasLocation W20449854621 @default.
• W2044985462 hasLocation W20449854622 @default.
• W2044985462 hasOpenAccess W2044985462 @default.
• W2044985462 hasPrimaryLocation W20449854621 @default.
• W2044985462 hasRelatedWork W1967914320 @default.
• W2044985462 hasRelatedWork W1982054347 @default.
• W2044985462 hasRelatedWork W1992256686 @default.
• W2044985462 hasRelatedWork W2020676616 @default.
• W2044985462 hasRelatedWork W2021342174 @default.
• W2044985462 hasRelatedWork W2027502904 @default.

• next